Cargando…

Gender difference in adiponectin associated with cardiovascular mortality

BACKGROUND: It is important to identify cardiovascular diseases in patients at high risk. To include genetics into routine cardiological patients has therefore been discussed recently. We wanted to evaluate the association between high-molecular weight adiponectin and cardiovascular risk, and second...

Descripción completa

Detalles Bibliográficos
Autores principales: Alehagen, Urban, Vorkapic, Emina, Ljungberg, Liza, Länne, Toste, Wågsäter, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631110/
https://www.ncbi.nlm.nih.gov/pubmed/26068642
http://dx.doi.org/10.1186/s12881-015-0187-9
_version_ 1782398816663633920
author Alehagen, Urban
Vorkapic, Emina
Ljungberg, Liza
Länne, Toste
Wågsäter, Dick
author_facet Alehagen, Urban
Vorkapic, Emina
Ljungberg, Liza
Länne, Toste
Wågsäter, Dick
author_sort Alehagen, Urban
collection PubMed
description BACKGROUND: It is important to identify cardiovascular diseases in patients at high risk. To include genetics into routine cardiological patients has therefore been discussed recently. We wanted to evaluate the association between high-molecular weight adiponectin and cardiovascular risk, and secondly in the same population evaluate if specific genotype differences regarding risk could be observed, and thirdly if gender differences could be seen. METHOD: Four hundred seventy-six elderly participants recruited from a rural community were included. All participants underwent a clinical examination, echocardiography, and blood sampling and the single nucleotide polymorphism (SNP) (rs266729) of adiponectin was analysed. Follow-up time was 6.7 years. RESULTS: Those with high serum concentration of adiponectin had a more 2 fold increased cardiovascular risk, and it might be that females exhibits even higher risk where a more than 5 fold increased risk could be seen. The result could be demonstrated even in a multivariate model adjusting for well-known clinical risk factors. However, as the sample size was small the gender differences should be interpreted with caution. In the genotype evaluation the C/C carriers of the female group had a more than 9-fold increased risk of cardiovascular mortality, however the confidence interval was wide. Such genotype difference could not be found in the male group. CONCLUSION: High level of adiponectin was associated with increased cardiovascular risk. Also a gender difference in the genotype evaluation could be seen where the C/C carriers obtained higher risk in the female group but not in the male group. Thus, in order to identify patients at risk early, genetic analyses may add to the armamentarium used in the clinical routine. However, information should be regarded as hypothesis generating as the sample size was small and should stimulate further research in individualized cardiovascular prevention and treatment.
format Online
Article
Text
id pubmed-4631110
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46311102015-11-04 Gender difference in adiponectin associated with cardiovascular mortality Alehagen, Urban Vorkapic, Emina Ljungberg, Liza Länne, Toste Wågsäter, Dick BMC Med Genet Research Article BACKGROUND: It is important to identify cardiovascular diseases in patients at high risk. To include genetics into routine cardiological patients has therefore been discussed recently. We wanted to evaluate the association between high-molecular weight adiponectin and cardiovascular risk, and secondly in the same population evaluate if specific genotype differences regarding risk could be observed, and thirdly if gender differences could be seen. METHOD: Four hundred seventy-six elderly participants recruited from a rural community were included. All participants underwent a clinical examination, echocardiography, and blood sampling and the single nucleotide polymorphism (SNP) (rs266729) of adiponectin was analysed. Follow-up time was 6.7 years. RESULTS: Those with high serum concentration of adiponectin had a more 2 fold increased cardiovascular risk, and it might be that females exhibits even higher risk where a more than 5 fold increased risk could be seen. The result could be demonstrated even in a multivariate model adjusting for well-known clinical risk factors. However, as the sample size was small the gender differences should be interpreted with caution. In the genotype evaluation the C/C carriers of the female group had a more than 9-fold increased risk of cardiovascular mortality, however the confidence interval was wide. Such genotype difference could not be found in the male group. CONCLUSION: High level of adiponectin was associated with increased cardiovascular risk. Also a gender difference in the genotype evaluation could be seen where the C/C carriers obtained higher risk in the female group but not in the male group. Thus, in order to identify patients at risk early, genetic analyses may add to the armamentarium used in the clinical routine. However, information should be regarded as hypothesis generating as the sample size was small and should stimulate further research in individualized cardiovascular prevention and treatment. BioMed Central 2015-06-12 /pmc/articles/PMC4631110/ /pubmed/26068642 http://dx.doi.org/10.1186/s12881-015-0187-9 Text en © Alehagen et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Alehagen, Urban
Vorkapic, Emina
Ljungberg, Liza
Länne, Toste
Wågsäter, Dick
Gender difference in adiponectin associated with cardiovascular mortality
title Gender difference in adiponectin associated with cardiovascular mortality
title_full Gender difference in adiponectin associated with cardiovascular mortality
title_fullStr Gender difference in adiponectin associated with cardiovascular mortality
title_full_unstemmed Gender difference in adiponectin associated with cardiovascular mortality
title_short Gender difference in adiponectin associated with cardiovascular mortality
title_sort gender difference in adiponectin associated with cardiovascular mortality
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631110/
https://www.ncbi.nlm.nih.gov/pubmed/26068642
http://dx.doi.org/10.1186/s12881-015-0187-9
work_keys_str_mv AT alehagenurban genderdifferenceinadiponectinassociatedwithcardiovascularmortality
AT vorkapicemina genderdifferenceinadiponectinassociatedwithcardiovascularmortality
AT ljungbergliza genderdifferenceinadiponectinassociatedwithcardiovascularmortality
AT lannetoste genderdifferenceinadiponectinassociatedwithcardiovascularmortality
AT wagsaterdick genderdifferenceinadiponectinassociatedwithcardiovascularmortality